In NSCLC, CAV1 overexpression has been associated with higher disease stage and inferior survival in patients with adenocarcinoma, but a robust correction of the survival data for stage and treatment was not done in these studies [24], [25], [26]. Here, CAV1 is linked to non-small cell lung carcinoma.